Efficacy of Intravenous Immunoglobulins and Other Immunotherapies in Neurological Disorders and Immunological Mechanisms Involved

QR Code

Efficacy of Intravenous Immunoglobulins and Other Immunotherapies in Neurological Disorders and Immunological Mechanisms Involved

This review aims to explore the role of immunotherapeutic strategies—primarily intravenous immunoglobulin (IVIG), plasma exchange (PLEX), and selected immunomodulatory agents—in the treatment of neurological and psychiatric disorders with suspected or confirmed autoimmune mechanisms. A central focus...

Full description

Saved in:

Bibliographic Details
Main Authors:	Angel Justiz-Vaillant, Sachin Soodeen, Odalis Asin-Milan, Julio Morales-Esquivel, Rodolfo Arozarena-Fundora
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Immuno
Subjects:	blood–brain barrier cytokines intravenous immunoglobulins neurological diseases antibodies
Online Access:	https://www.mdpi.com/2673-5601/5/2/18
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

EFFICACY OF INTRAVENOUS IMMUNOGLOBULINS IN COMPLEX TREATMENT OF PERINATAL INFECTIONS IN PRETERM NEONATES
by: V.A. Bushtyriev, et al.
Published: (2006-03-01)

Peculiar features of intravenous immunoglobulins application in rheumatic diseases
by: O. N. Egorova, et al.
Published: (2024-06-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

Intravenous immunoglobulin for intensive therapy of fibrosing alveolitis in a patient TOC \o "1-5" \h \z with systemic sclerosis
by: R T Alekperov, et al.
Published: (2004-02-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

Adverse Reactions to Intravenous Immunoglobulin Therapy: An Analysis of the Russian National Pharmacovigilance Database
by: A. V. Nechaev, et al.
Published: (2024-12-01)

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01)

Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)

Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases
by: Elena Aleksandrovna Aseeva, et al.
Published: (2014-03-01)

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages
by: Tatyana V. Sleptsova, et al.
Published: (2016-09-01)

Intravenous high-dose immunotherapy: practical recommendations for use in the treatment of neurological disimmune diseases
by: N. A. Suponeva, et al.
Published: (2015-12-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients
by: Dominic McGrosso, et al.
Published: (2025-07-01)

Effects of intravenous immunoglobulin on the negatively transformed subpopulations of neutrophilic granulocytes in newborns with congenital pneumonia and neonatal sepsis
by: I. V. Nesterova, et al.
Published: (2024-01-01)

Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
by: N. M. Tereshchenko, et al.
Published: (2023-04-01)

Immunoglobulins in neurological practice: a review of the literature
by: S. S. Nikitin, et al.
Published: (2019-04-01)

Intravenous immunoglobulins and recombinant granulocyte-colony stimulating factor modulate expression of NK cytotoxic receptors
by: A. A. Davydova, et al.
Published: (2024-11-01)

Impact of Onset-to-Needle Time on the Risk of Early Neurological Deterioration in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis
by: Hu B, et al.
Published: (2025-06-01)

Рrospective multicenter study of treatment efficacy, safety, and quality of life in a large cohort of patients with inborn errors of immunity receiving subcutaneous immunoglobulin by the rapid push method
by: Asmik Avedova, et al.
Published: (2025-07-01)

THE SONOGRAPHIC DYNAMICS OF PERIPHERAL NERVES CROSS SECTIONAL AREA CHANGES IN MULTIFOCAL MOTOR NEUROPATHY TREATED WITH INTRAVENOUS IMMUNOGLOBULIN: CASE REPORT
by: S. S. Nikitin, et al.
Published: (2017-01-01)

Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide study
by: Pedro Moral Moral, et al.
Published: (2025-07-01)

Possibility to Obtain Anti-Athrax Human Immunoglobulin for Intravenous Injection
by: V. Yu. Dolmatov, et al.
Published: (2008-04-01)

Principles and practice of intravenous therapy /
by: Plumer, Ada Lawrence
Published: (1982)

Neurological Manifestations of HEV Infection: A Rare Phenomenon or an Underrecognized Reality?
by: Maider Iza, et al.
Published: (2025-06-01)

EFFECTS OF IVIG TREATMENT UPON LOCAL AND GENERAL IMMUNITY STATE IN THE PATIENTS WITH ACUTE EPIGLOTTITIS
by: A. V. Savchenko, et al.
Published: (2014-07-01)

Association Between Thymosin &beta;4 and&nbsp;Coronary Arterial Lesions in Children with Kawasaki Disease
by: Wu J, et al.
Published: (2025-07-01)

Clinical and immunological features and treatment of myasthenia gravis in the elderly (review)
by: T. M. Alekseeva, et al.
Published: (2019-04-01)

Features of high-dose intravenous immunotherapy administration in patients with reduced IgA level in neurological practice: literature review and description of a clinical case
by: A. S. Rizvanova, et al.
Published: (2018-10-01)

Pharmacoeconomic analysis of treatment of children with acute lymphoblastic leukemia according to ALL-MB-2002 protocol
by: N. V. Miga, et al.
Published: (2022-11-01)

Limited efficacy of adjunctive therapy in a case of severe herpes simplex virus encephalitis: A case report and literature review
by: Xiao-Ling Zhong, et al.
Published: (2025-01-01)

HAEMAGGLUTINATION TECHNIQUES TO EVALUATE SPECIFIC SAFETY OF HUMAN INTRAVENOUS IMMUNOGLOBULINS
by: O. G. Kornilova, et al.
Published: (2017-10-01)

OPSONIZING PROPERTIES OF A COMMERCIAL ANTISTAPHYLOCOCCAL IMMUNOGLOBULIN
by: S. V. Slobodchikova, et al.
Published: (2014-07-01)

Comparative acute toxicity of intravenous paclitaxel and sirolimus in rats
by: Jing Xie, et al.
Published: (2025-01-01)

Paraneoplastic neurologic syndromes in breast cancer: Immunological mechanisms and therapeutic insights
by: Carolina Coradi, et al.
Published: (2025-12-01)

Intravenous prostacyclin analogue iloprost (Ilomedin®) in the treatment of a patient with Buerger’s disease
by: Ilshat Ravilevich Gaisin, et al.
Published: (2013-03-01)